Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage

PHASE3RecruitingINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

December 3, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
DRUG

Dexamethasone

3 x 8 mg dexamethasone daily for days 1-7 and 1 x 8 mg dexamethasone daily for days 8-21

DRUG

Placebo

3 x 2 ml Placebo daily for days 1-7 and 1 x 2 ml Placebo daily for days 8-21

Trial Locations (13)

10117

RECRUITING

Charité-Universitätsmedizin Berlin, Berlin

20246

RECRUITING

University Medical Center Hamburg-Eppendorf, Hamburg

30625

RECRUITING

Hannover Medical School, Hanover

39120

RECRUITING

Otto von Guericke University Magdeburg, Magdeburg

45147

RECRUITING

University Hospital of Essen, Essen

50937

RECRUITING

University of Cologne, Cologne

53127

RECRUITING

University Hospital Bonn, Bonn

60529

RECRUITING

Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main

72076

RECRUITING

Eberhard Karls University of Tübingen, Tübingen

81675

RECRUITING

Klinikum rechts der Isar, School of Medicine, Technical University of Munich, München

89312

RECRUITING

University of Ulm/BKH Günzburg, Günzburg

93053

RECRUITING

University Medical Center Regensburg, Regensburg

04103

RECRUITING

University Hospital Leipzig, Leipzig

All Listed Sponsors
collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Pharmacy of the University Hospital Leipzig- AöR

UNKNOWN

collaborator

nextevidence GmbH

UNKNOWN

lead

University Hospital, Bonn

OTHER